Background. Human bocavirus (HBoV) 1 can cause life-threatening respiratory tract infection in children. Diagnosing acute HBoV1 infection is challenging owing to long-term airway persistence. We assessed whether messenger RNA (mRNA) detection would correlate better than DNA detection with acute HBoV1 infection.
avidity, and seroconversion or diagnostic (≥4-fold) increase in the IgG level in paired serum samples [3, 7, [10] [11] [12] [13] [14] [15] [16] [17] [18] . All of these markers, however, have individual advantages and limitations [3, 19] . Lately, reverse-transcription (RT) PCR measuring HBoV1 messenger RNA (mRNA), a marker of viral activity, has been applied to distinguish acute infection from DNA persistence, and an association of mRNA positivity with high DNA load has been observed [20, 21] . However, until now, it has not been known how mRNA detection correlates with acute HBoV1 infection.
The aim of our study was to assess whether viral mRNA RT-PCR would be a more accurate diagnostic method for defining acute HBoV1 infection than DNA PCR and to compare these test performances with high DNA load by quantitative PCR (qPCR) and serological acute-infection markers by enzyme immunoassay (EIA). Nasopharyngeal swab (NPS) and serum samples were obtained at the acute phase and 2 weeks, 2 months, and 1 year later, from 121 wheezing children.
children with ARTI as part of their care at the Turku University Hospital. For the diagnostic comparisons, we obtained paired serum and NPS samples obtained during the acute-phase (at hospital admission), the convalescent phase (2 weeks later), and 1 year later, from 121 children with acute wheezing (age range, 3-23 months; median 11 months), collected during 2007-2009 [22] . Additional NPS samples were collected at 2 months. Serum samples were stored at −20°C, and NPS samples were suspended in 1 mL of phosphate-buffered saline and stored at −70°C until analysis. The prospective study was approved by the Ethics Committee of the Hospital District of Southwest Finland, and informed consent was obtained from the parents of the children. Informed consent was waived for reanalysis of the deidentified routine samples. All ethics guidelines of the Hospital District of Southwest Finland were followed in the research conduct.
Viruslike Particle-Based EIAs
HBoV1 IgG and IgM antibodies were measured in all available serum samples from the 121 wheezing children, and IgG avidity was measured for those children lacking acute-phase serum samples, by in-house EIA based on viruslike particles (VLPs) of recombinant major capsid proteins (VP3), as described elsewhere [7, 12, 19] . For IgG-avidity EIA, and to verify that the IgG result was HBoV1 specific in all HBoV1 acutely infected children, the serum samples were blocked with HBoV2 and HBoV3 nonbiotinylated VLPs [11, 12, 19] . The positivity cutoffs in competitive and noncompetitive IgG EIA were 0.095 (mean + 3 standard deviations [SDs]) and 0.154 (mean + 3 SDs), respectively, and in noncompetitive IgM EIA, 0.136 (mean + 3 SDs) [19] . The cutoffs for low and high IgG avidity were 15% and 25%, respectively [12] .
Real-Time qPCR for HBoV1
All 80 NPS assay-setup routine samples underwent qPCR. Of the 121 wheezing children, all acute-phase and follow-up NPS samples from the 18 children who were initially IgM positive underwent further analysis by qPCR. In addition, 23 serologically selected wheezing children without an acute HBoV1 infection served as negative controls. This strict selection was based on foolproof nonacute serology (negative IgM with maternal or past-infection IgG or seronegative throughout follow-up with no prior HBoV2 or 3 antibodies) and availability of all 3 serum samples. Furthermore, serum samples from 2 children with recent HBoV1 infection were studied for viremia by qPCR.
Total DNA was extracted from 100 µL of an NPS sample in phosphate-buffered saline with QIAamp DNA Blood Mini Kit (Qiagen), according to the manufacturer's instructions. HBoV1 DNA was quantified by an in-house real-time quantitative PCR (qPCR), targeting the left-hand noncoding region and the beginning of the NS1 gene of the HBoV1 genome, as described elsewhere [23] , except the template volume was 2.5 µL. All samples were analyzed in duplicate. The amplification standard was used to quantify viral DNA by using 10-fold dilutions of plasmid pST2 containing the near-full-length HBoV1 genome (kind gift from Tobias Allander). All qPCR results with quantifiable DNA and cycle threshold (Ct) <40 were considered positive, and qPCR results ≥10 6 copies/mL were considered high load.
RT-PCR for Spliced HBoV1 mRNA
RT-PCR was performed on all 80 assay-setup NPS samples and on all acute-phase NPS samples from 18 wheezing children with acute or recent HBoV1 infection and of the 23 negative controls, as well as on all qPCR-positive follow-up samples. Total RNA was extracted from 200-µL respiratory specimens by GenElute Mammalian Total RNA Miniprep Kit (SigmaAldrich). A 2-step HBoV1-specific semiquantitative RT-PCR was used, which amplifies spliced HBoV1 mRNAs [20] . The primer and probe sequences are shown in Table 1 . The primer pairs cover the untranslated region of the HBoV1 genome and the beginning of the NP1 gene. The RT-PCR amplifies 2 main segments of the mRNA transcripts, 242 base pairs (bp) spliced at positions 241-2236, and 363 bp spliced at positions 241-2044 and 2164-2236 [24] . The hydrolysis probe targets the untranslated region upstream of the NP1 gene.
The RT of mRNA was performed at 37°C for 60 minutes with 1 µL of M-MLV Reverse Transcriptase (Life Technologies) and 200 ng of random hexamers (Promega). The RT products were subjected to qPCR: 1× PerfeCTa Multiplex qPCR SuperMix (Quanta Biosciences), 0.4 µmol/L forward and reverse primers, 0.15 µmol/L probe, and a 5-µL complementary DNA (cDNA) template. The amplification was conducted at 95°C for 3 minutes, followed by 45 cycles at 95°C for 5 seconds and 55°C for 30 seconds, using a Stratagene Mx3005P system (Agilent Technologies). The baseline-corrected fluorescence (dRn) was determined automatically by the Mx4000 4.1 software. The Ct for quantification cycles was 10 times the SD of fluorescence baseline in cycles 5-9.
RT-PCR for each sample was performed in triplicate. RNA without the RT enzyme (non-RT) served as control in RT-PCR for amplification of the virus genome. Only samples positive by RT-PCR but negative by non-RT PCR were considered mRNA positive. Three samples that were positive with the non-RT PCR were retested after DNase I treatment to remove genomic DNA before RT-PCR, and the PCR products were visualized by means of gel electrophoresis. Sequencing verified the spliced mRNA sequences.
Analytical sensitivity of the HBoV1 mRNA PCR assay was measured with a plasmid (pCR4-TOPO; kind gift from Andreas Christensen) containing the target PCR product, by testing 8 replicates of plasmid dilutions 10 -2 to 10 2 per reaction, on 2 separate days. PCR efficiency was measured serially diluting 100 ng of cDNA from a HBoV1 mRNA-positive sample, according to this equation: E = [10 (−1/slope) − 1] × 100. In addition, RT-PCR of the human housekeeping gene, RNA polymerase II (RPII) mRNA, was set up to confirm the RNA extraction and RT steps. The primers and probe for RPII mRNA RT-PCR are listed in Table 1 [25] .
Statistical Analysis
Log 10 transformation was performed to normalize data distributions. We used 1-way analysis of variance to examine the viral load as shown by qPCR . To analyze the HBoV DNA load of mRNA-positive versus mRNA-negative children, we used a 2-tailed t test. These analyses were conducted using IBM SPSS statistics software (version 19; SPSS). Differences were considered statistically significant at P < .05.
RESULTS

HBoV1 RT-PCR Setup Samples
Of the 80 NPS samples, 46 were HBoV1 DNA positive, among which HBoV1 mRNA was detected in 26 (57% of 46 NPS samples), all with a high viral DNA quantity of ≥10 6 copies/ mL (median, 6.1 × 10 8 copies/mL). Of the 20 mRNA-negative but DNA-positive NPS samples, 19 had low viral DNA loads (median, 3.4 × 10 3 copies/mL; range, 3.0 × 10 2 to 9.3 × 10 5 copies/mL), and 1 had a high DNA load (4 × 10 6 copies/mL) (P < .001; Figure 1 ). All 34 DNA-negative NPS samples were mRNA negative. Compared with mere DNA positivity, measured using in-house qPCR, the clinical sensitivity of mRNA RT-PCR was 57%, the specificity 100%, and the positive predictive value (PPV) 100%. However, compared with high-load DNA (≥10 6 copies/mL), the clinical sensitivity of mRNA RT-PCR improved to 96%, whereas both specificity and PPV remained at 100%.
Serology in Wheezing Children
Of the 121 children in the acute wheezing phase, 16 (13.2%) exhibited acute HBoV1 infection with both IgM positivity and diagnostic IgG ( Figure 2) ; these included 9 with seroconversion, 4 with ≥4-fold increases, 1 with a steady IgG level and low avidity (10.3%), and 2 (lacking acute-phase serum samples) with low IgG avidity (11.6% and 7.1%; cutoff, 25%) in the convalescent-phase serum samples [12] . Only 1 child, with paired serum samples available, showed seroconversion for both IgM and IgG. The duration between onset of fever and admission was consistent regardless of the serological kinetics (within 0-3 days in all, excluding 2 without fever; data not shown). With other symptoms (cough, rhinitis), the parental estimates appeared too ambiguous for exact comparison. Two additional children had recent HBoV1 infection, deduced from single available convalescent-phase samples, which were IgM positive but had IgG avidity results (33.5% and 27.3%), exceeding the upper cutoff and pointing to HBoV1 infection a few (or more) months ago, incompatible with the onset of fever reported 2 days or 1 day, respectively, before admission. The IgG responses were HBoV1 specific, based on VLP competition [11] .
Of the 105 wheezing children without acute HBoV1 infection, 30 (29%) were regarded as having prior immunity, 14 (13%) had maternal waning IgG, and 61 (58%) were seronegative. Borderline or very low (likely maternal) IgG results were considered negative. Thirty-seven seronegative children seroconverted later at the 1-year follow-up. The HBoV1 IgG and IgM seroprevalences in wheezing children varied with age ( Figure 2) . Acute primary infection, defined serologically, was most frequent (32%) in children aged 12-14 months, whereas the IgG seroprevalences in the different age groups varied between 21% and 75% (columns in Figure 2 ). In contrast, at the 1-year follow-up of the oldest children, who were 3 years old at the time, 100% were HBoV1 IgG seropositive (line in Figure 2 ). Interestingly, IgM EIA of 2 children with acute HBoV1 infection remained positive at 1 year. One initially seronegative child experienced a combined IgM and IgG seroconversion during follow-up.
Presence and Load of Viral DNA in NPS Samples From Wheezing Children
Of the 16 wheezing children with serologically diagnosed acute HBoV1 infection, all had HBoV1 DNA in NPS samples detected with the in-house qPCR during the acute wheezing phase ( Figure 3 ; Table 2 ). Of these 16 children, 13 (81%) showed high viral DNA loads (≥10 6 copies/mL; median 1.1 × 10 8 copies/mL), and 3 (19%) showed low loads of 6.5 × 10 1 , 1.2 × 10 5 , or 8.5 × 10 4 copies/mL. In the convalescent phase, the viral loads of 9 DNA-positive samples were low (median. 5.1 × 10 2 copies/ mL; range, 2.5 × 10 2 to 8.0 × 10 4 copies/mL; Figure 3 ).
Airway persistence of HBoV1 DNA at low DNA loads was seen for 2 months in 3 of the 16 children with acute infection. None had HBoV1 DNA for 12 months. Of note, a 1-year-old child had 5 × 10 8 copies/mL of viral DNA during the acute phase, after which the DNA was undetectable at 2 weeks, but positive again (1.3 × 10 2 copies/mL) at 2 months. On the opposite, b High viral load was defined as ≥10 6 copies/mL; low viral load, as <10 6 copies/mL.
another 1-year-old child had his highest level of HBoV1 DNA (8 × 10 4 copies/mL) during the convalescent phase and was still shedding virus at 2 months. Persistence of viral DNA did not correlate with the viral load in the acute phase. In addition to the 16 children with acute HBoV1 infection, 2 had had fairly recent infection, evidenced by IgM positivity combined with high IgG avidity in the convalescent-phase serum samples; 1 of these 2 was DNA negative by qPCR of the NPS sample, and the other was DNA positive with a high viral load. Neither had detectable HBoV1 DNA in serum samples; however, only convalescent-phase serum samples were available. Of the 23 control children without acute or recent HBoV1 infection, 5 had NPS samples that were qPCR positive, 1 with a high viral load of 1.8 × 10 6 copies/ mL and the other 4 with very low loads of 1-5 × 10 2 copies/mL. Of the 5 DNA-positive control children, 4 had prior HBoV1 immunity, and 1 was seronegative throughout the 1-year follow-up; He was also seronegative for HBoV2 and HBoV3.
HBoV1 mRNA RT-PCR in Wheezing Children
During the acute wheezing phase, HBoV1 mRNA was detected in 13 of the 41 NPS samples, all with high HBoV1 viral loads (median 1.1 × 10 8 copies/mL). Of these 13 children, 12 had serologically proved acute HBoV1 infections and 1 had a recent infection. Of the 16 children with an HBoV1 serodiagnosis, 4 (25%) had NPS samples that were mRNA negative, 1 of them with a high DNA load, and 12 (75%) were mRNA positive ( Table 2) . None of the 18 DNA-negative control children were RT-PCR positive. However, 9 DNA-positive NPS samples, 2 with high DNA loads and all 7 with low DNA loads (median, 2.6 × 10 2 copies/mL) were HBoV1 mRNA negative (P < .001; Figure 4 , Table 2 ). No HBoV1 mRNA was found in the corresponding NPS samples at 2 weeks, 2 months, or 12 months. All mRNA-positive reactions had a Ct between 29.6 and 38.7.
The HBoV1 RT-PCR products were subjected to gel electrophoresis, and 2 bands were shown at approximately 250 and 350 bp. The sequencing results of the 2 bands were identical with the spliced mRNA. Only 3 mRNA-positive NPS samples were also positive in the non-RT-PCR control, but these became negative after DNase I treatment, whereas repeated RT-PCR of the DNase-treated sample still had positive results.
The analytical sensitivity of the RT-PCR, determined by serial dilution of the control cDNA plasmid, was <5 copies per reaction. The amplification efficiency of the RT-PCR was 95%-105%, suggesting minimal inhibition. Human RPII mRNA RT-PCR was positive in all respiratory samples studied, except 1 HBoV1 mRNA-positive sample and 2 DNA-negative samples from children with past immunity.
Clinical Performance Characteristics of HBoV1 mRNA RT-PCR and qPCR
Compared with qPCR demonstration of high-load DNA, HBoV1 mRNA RT-PCR in the wheezing children cohort had a clinical sensitivity of 87%, a specificity of 100%, and a PPV of 100%. Using serology (IgM positivity and IgG increase or low IgG avidity) as a strict criterion for HBoV1 diagnosis, the diagnostic sensitivity of mRNA RT-PCR was 75%, the specificity 96%, and the PPV 92% ( Table 2 ). The sensitivity, specificity and PPV were 100%, 76%, and 73%, respectively, for the mere presence of viral DNA, and 81%, 92%, and 87% for high viral load (≥10 6 copies/mL).
DISCUSSION
HBoV1 infection is a frequent cause of acute wheezing in young children and can even be life-threatening. In laboratory diagnosis of respiratory infections, PCR is a commonly used method. However, HBoV1 DNA persists in the respiratory tract long after infection rendering PCR unreliable [4] [5] [6] [7] [8] [9] [10] . Our study showed persistence of viral DNA in NPS samples from 9 of 16 children at 2 weeks and 3 of 16 at 2 months after the diagnosis of acute HBoV1 infection at admission; however, no child had viral DNA detectable 1 year later. In addition, 5 children among the 23 nonacute controls had viral DNA in NPS samples. Owing to this persistence, the mere presence of HBoV1 DNA in respiratory specimens is not a diagnostic marker of acute HBoV1 infection.
HBoV1 infection can also be diagnosed using more reliable methods, such as serology, DNA PCR in blood samples, and qPCR and antigen detection in respiratory specimens [7, 11, 12, 16, 23, [26] [27] [28] . However, these methods also have pitfalls. Serology is not always straightforward, owing to immunological cross-reactivity with the 3 closely related enteric bocaviruses, HBoV2, HBoV3, and HBoV4 [11] . Furthermore, HBoV1 infections in individuals with pre-existing HBoV2 or HBoV3 immunity may be difficult to detect serologically, owing to the immunological phenomenon called original antigenic sin or imprinting [19, 29] .
Limited availability of serum can restrict the use of serology, as well as of DNA amplification in blood. Detection of a high load of virus in the airways has been shown to be linked with monoinfection and acute infection [4, 7, [13] [14] [15] [16] , but this is not necessarily clinically infallible. Some PCR-negative children and even a third of children with low HBoV1 DNA loads may, as evidenced by serology, have acute infection [7] . In line with this, our present study detected viral DNA in NPS samples at low loads in 3 children with acute infection and at high loads in 2 children with past immunity. Interestingly, 1 child seronegative through follow-up had NPS samples transiently positive for viral DNA at a low load, possibly owing to superficial infection or mucosal contamination among children closely interacting with each other in daycare surroundings [5, 30] .
An RT-PCR test measuring mRNA, a sign of virus activity, was described to remedy the problems of HBoV1 diagnosis; it was shown to correlate with high viral load and was thus suggested to be a useful diagnostic marker [20, 21] . However, RT-PCR findings have not been directly correlated with acute HBoV1 infection. Our study aimed to correlate the detection of mRNA with serodiagnosed acute HBoV1 infection, and to compare the clinical performance of this test with those of qPCR and serology.
Compared with high-load viral DNA, here defined as ≥10 6 copies/mL, mRNA RT-PCR of the 80 RT-PCR setup samples displayed excellent performance, with high sensitivity and specificity, in line with findings of previous studies [20, 21] , and with a somewhat lower sensitivity of 87% among the wheezing children. With serology as the reference standard, testing for the presence of viral DNA with qPCR did not, as expected, perform well; although the clinical sensitivity was high (100%), the specificity was low (76%). By contrast, mRNA RT-PCR, compared with serology, exhibited high specificity (96%) but low sensitivity (75%). There are several possible reasons for low sensitivity of RT-PCR in general. Degradation of mRNA during handling, shipping, or storage is one. Other possible factors include nonoptimal swab sampling. In this study, however, all but 3 NPS samples (95%) were human mRNA positive, pointing to mRNA intactness-1 of the 3 was HBoV1 mRNA positive, and the other 2 were HBoV1 DNA-negative samples from children with past immunity. If the sample is aspirate, one should be careful to include the mRNA-containing cells and not only the supernatant.
The kinetic difference between virus replication and antibody induction is another caveat that must be considered when comparing virus detection with serology. HBoV1 mRNA is thought to be expressed only during active replication and to have a short life span; however, this has not been proved. Neither is it known whether the persisting HBoV1 DNA in NPS samples is formed during continuous active replication or only by passive release from the tissues of nonreplicating virus. According to an estimate based on antigen and mRNA detections, the duration of active HBoV1 infection in a young child was <1 week, also concurring with the severity of illness [28] ; however, the incubation time for HBoV1 infection is not known. IgM, a serological marker of acute infection, generally appears within 1 week after infection, thereby matching quite well with the phase of mRNA detection and also the admission time, which depends on symptom onset and severity.
In the present study, most children with acute HBoV1 infection were already IgM positive (but IgG negative) in the first serum sample, obtained 0-2 days (mean, 1.0 days) after onset of fever, whereas 1 child also seroconverted for IgM-with a DNA-positive but mRNA-negative acute-phase NPS samplewith fever onset 2 days before sampling. There was no difference in fever onset between children with IgG conversion and those who were already positive for IgG and IgM at admission (0-3 days; mean, 1.3 day; P = .53), exemplifying the kinetic diversity.
Moreover, IgM results may remain positive for months. Two children in our study had IgM positivity for 12 months, indicating that such positivity by itself is not proof of acuteness. In this study, acute infection was therefore staged not only by IgM positivity, but also by seroconversion or ≥4-fold increase of IgG or low IgG avidity. Viremia, in turn, has been shown to be rather short-lived and a good marker of acute infection [7, 16] . Owing to the shortage of serum samples, we did not analyze all serum samples with qPCR, but we did perform qPCR on the available convalescent-phase serum samples from the 2 children with recent infection, which were negative. Although not by itself ruling out acute infection, this result conforms with the nonacute HBoV1 status of the children.
In summary, based on results from serology of paired samples, we showed that 16 of 121 wheezing children had a definitive HBoV1 acute primary infection, 25% of whom were negative for HBoV1 mRNA in NPS samples, whereas all had qPCR-positive NPS samples, including 3 with low DNA loads. Two more children had HBoV1 infection about 2-4 months before admission, 1 of whom had both viral mRNA and a high load of viral DNA in NPS samples; the other child was DNA and mRNA negative. In conclusion, no test alone is sufficient in all instances; for accurate HBoV1 diagnosis in severe infections, qPCR of NPS and serum samples, RT-PCR of NPS samples, and serology of paired serum samples should be combined and considered together with other laboratory data, the clinical picture, and the time of symptom onset. 
